RIV.V - Canopy Rivers Inc.

TSXV - TSXV Delayed Price. Currency in CAD
3.0800
+0.0900 (+3.01%)
As of 1:14PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close2.9900
Open3.0400
Bid3.0800 x 0
Ask3.0900 x 0
Day's Range2.9300 - 3.2000
52 Week Range0.1550 - 6.3300
Volume290,836
Avg. Volume406,561
Market Cap172.305M
Beta (3Y Monthly)N/A
PE Ratio (TTM)19.74
EPS (TTM)0.1560
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.09
  • Benzingayesterday

    Canopy Rivers Reports Q4 Earnings

    A venture capital investment company that seeks opportunities in the cannabis industry, Canopy Rivers (TSXV: RIV) (OTC: CNPOF ) released its financial report for the fourth quarter and fiscal year on Tuesday. ...

  • PR Newswireyesterday

    Canopy Rivers Reports Fourth Quarter and Fiscal Year 2019 Financial Highlights and Provides Corporate Update

    TORONTO, July 16, 2019 /PRNewswire/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (RIV.V) (CNPOF) today released its financial results for the three and twelve months ended March 31, 2019. The Company's audited consolidated financial statements for the twelve months ended March 31, 2019, and its full Management's Discussion and Analysis (the "MD&A") for the three and twelve months ended March 31, 2019, are available under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/financials. "It was a year full of milestones and significant achievements for Canopy Rivers," said Narbe Alexandrian, President and Chief Executive Officer of Canopy Rivers.

  • Market Exclusive7 days ago

    Cannabis Stock News Daily Roundup July 10

    Zenabis Global (OTCMKTS:ZBISF) has submitted its site evidence package to Health Canada for the first phase of its facility in Langley. Called Zenabis Langley, the facility’s first 50,000 sq. ft. flower room is substantially complete, while work on the remaining five flower rooms and additional support space, totaling 380,000 sq. ft., is set to complete […]The post Cannabis Stock News Daily Roundup July 10 appeared first on Market Exclusive.

  • Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta
    CNW Group8 days ago

    Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta

    TORONTO , July 9, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) congratulates its portfolio company, YSS Corp. ("YSS") (TSXV:YSS) (WKN:A2PMAX), on receiving five cannabis retail licences from the Alberta Gaming, Liquor and Cannabis Commission ("AGLC"). Canopy Rivers currently holds approximately 8% of the issued and outstanding common shares in the capital of YSS on a fully-diluted basis.

  • Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada
    CNW Group9 days ago

    Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada

    TORONTO , July 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation ("JWC") (JWCA.V) (JWCAF), has received approval of a licence amendment from Health Canada. This licence amendment allows for the sale of formulated cannabis oil from JWC's pilot facility in Kitchener, Ontario .

  • Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada
    CNW Group9 days ago

    Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada

    TORONTO , July 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) congratulates its portfolio company TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF) on its announcement today that it has received an amendment to its licence from Health Canada allowing for the sale of cannabis oils from its facility in Mississauga, Ontario . This news comes two months following TerrAscend's announcement that it had been issued a Good Manufacturing Practice (GMP) certificate in accordance with the rules governing medical products in the European Union, in conjunction with establishing a sales and distribution agreement with iuvo Therapeutics GmbH, a German pharmaceutical wholesaler. "With another key milestone achieved by TerrAscend in a matter of a few short months, the company continues to demonstrate its ambition to become a global provider of pharmaceutical-grade cannabis products," said Narbe Alexandrian, President and CEO of Canopy Rivers.

  • Market Exclusive12 days ago

    Cannabis Stock News Daily Roundup July 5

    Cannabis Stock News The Cannabis Council of Canada (C3) applauded the Government of Ontario for their decision to expand adult use retail cannabis licenses. With national cannabis supply levels improving, C3 believes that the continued and sustained expansion of Ontario's retail network will be a key factor in replacing the illicit cannabis market with a legal […]The post Cannabis Stock News Daily Roundup July 5 appeared first on Market Exclusive.

  • CNW Group14 days ago

    Canopy Rivers Announces Change to Board of Directors

    Canopy Rivers Announces Change to Board of Directors

  • CNW Group28 days ago

    Canopy Rivers to Report Fourth Quarter and Fiscal Year 2019 Financial Results

    TORONTO , June 19, 2019 /CNW/ - Canopy Rivers Inc. (the "Company") (RIV.V) (CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2019 before markets open on Tuesday, July 16, 2019 . The Company's audited consolidated financial statements and Management's Discussion and Analysis for the three and twelve months ended March 31, 2019 will be available on the Company's profile on SEDAR at www.sedar.com and in the Investors section of the Company's website at www.canopyrivers.com. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC), which are currently scheduled to be released on June 20, 2019 .

  • PR Newswire28 days ago

    Canopy Rivers Makes US$10 Million Investment in Plant Genetics Innovator ZeaKal

    TORONTO and SAN DIEGO, June 19, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers", the "Company") (RIV.V) (CNPOF) and ZeaKal, Inc. ("ZeaKal") are pleased to announce an investment and strategic collaboration between Canopy Rivers and ZeaKal, a California-based plant science innovator with proprietary technologies that sustainably increase photosynthesis, improve plant yield and enhance nutritional profiles for a variety of agricultural crops. The investment from Canopy Rivers marks another significant corporate milestone this calendar year for ZeaKal, following the February announcement of its R&D collaboration (link) with Corteva Agriscience (NYSE:CTVA), the recently spun-out and NYSE-listed agricultural science division of DowDuPont.

  • CNW Grouplast month

    Canopy Rivers announces grant of options

    Canopy Rivers announces grant of options

  • Market Exclusive2 months ago

    Agripharm Wins Approval for Outdoor Cultivation License

    Canopy Rivers (TSXV: RIV) (OTC: CNPOF) announced that its portfolio company Agripharm Corp. received its outdoor cultivation license from Health Canada. Agripharm is co-owned by SLANG (CNSX: SLNG), Canopy Growth (NYSE: CGC) and Green House Holdings North America and received a strategic investment from Canopy Rivers. Canopy Rivers provided the capital to finance the build-out […]The post Agripharm Wins Approval for Outdoor Cultivation License appeared first on Market Exclusive.

  • PR Newswire2 months ago

    Canopy Rivers Hosts Analyst and Investor Day on May 28 - Live Webcast Available

    TORONTO, May 28, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V), (CNPOF) will be hosting its analyst and investor day from 1:00 p.m. to 5:00 p.m. ET today, May 28. The webcast will be available on Canopy Rivers' website immediately prior to the event at www.canopyrivers.com/investors/events. Bruce Linton, Chairman of the Board, will share his perspective on Canopy Rivers' unique value proposition.  This will be followed by a presentation from senior executives addressing Canopy Rivers' priorities in support of its mission to accelerate success in the global cannabis economy.

  • PR Newswire2 months ago

    Canopy Growth subsidiary and Canopy Rivers portfolio company Vert Mirabel now fully licensed by Health Canada

    MIRABEL, QC, May 28, 2019 /PRNewswire/ - Les Serres Vert Cannabis Inc. ("Vert Mirabel"), a subsidiary of Canopy Growth Corporation (WEED.TO) (CGC) ("Canopy Growth") and a portfolio company of Canopy Rivers Inc. (RIV.V) (CNPOF) ("Canopy Rivers") has received its final cultivation licence from Health Canada. All 700,000 sq. ft. of operating space at Vert Mirabel is now licensed for cannabis production. Vert Mirabel was established in December 2017 between Canopy Growth, Canopy Rivers, and Les Serres Stéphane Bertrand ("Bertrand"). "We are thrilled that the operational infrastructure at Vert Mirabel is now fully online with over 500,000 sq. ft. already in production," said Olivier Dufourmantelle, Chief Operating Officer, Canopy Rivers.

  • PR Newswire2 months ago

    Canopy Rivers Hosts analyst and Investor Day

    TORONTO, May 23, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) today announced that it will host an analyst and investor day on Tuesday, May 28 from 1:00 p.m. to 5:00 p.m. ET. Bruce Linton, Chairman of the Board, will share his perspective on Canopy Rivers' unique value proposition. This will be followed by a presentation from senior executives addressing Canopy Rivers' priorities in support of its mission to accelerate success in the global cannabis economy.